Diabetic KetoacidosisSymptoms, Doctors, Treatments, Advances & More
Diabetic Ketoacidosis Overview
Learn About Diabetic Ketoacidosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Grady Memorial Hospital Corporation
Guillermo Umpierrez is an Endocrinologist practicing medicine in Atlanta, Georgia. Dr. Umpierrez is rated as an Elite provider by MediFind in the treatment of Diabetic Ketoacidosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Diabetic Ketoacidosis, Low Blood Sugar, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.
Grady Memorial Hospital Corporation
Priyathama Vellanki is an Endocrinologist practicing medicine in Atlanta, Georgia. Dr. Vellanki is rated as an Elite provider by MediFind in the treatment of Diabetic Ketoacidosis. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Diabetic Ketoacidosis, Low Blood Sugar, Type 2 Diabetes (T2D), End-Stage Renal Disease (ESRD), and Coronary Artery Bypass Graft (CABG).
Baylor College Of Medicine - Endocrinology
Ashok Balasubramanyam, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Ashok Balasubramanyam specializes in Endocrinology, Diabetes and Metabolism and works at BCM Medicine - Endo. To make an appointment, please call (713) 798-0180. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Balasubramanyam is rated as an Elite provider by MediFind in the treatment of Diabetic Ketoacidosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diabetic Ketoacidosis, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Balasubramanyam is currently accepting new patients.
Summary: Minoritized individuals with type 1 diabetes (T1D) have approximately 2% higher average A1c levels and twice the rate of hospitalizations, complications, and mortality as their white counterparts. However, the efficacy trials establishing the benefits of hybrid closed loop (HCL) pump therapy in T1D have been in more socially advantaged and predominantly non-Hispanic white patients. Use of this tec...
Summary: Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because of the few studies in this population, due to concerns about the increase in risk of diabetic ketoaci...